Conmed Stock Performance
| CNMD Stock | USD 38.79 0.42 1.07% |
The firm shows a Beta (market volatility) of 0.82, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CONMED's returns are expected to increase less than the market. However, during the bear market, the loss of holding CONMED is expected to be smaller as well. At this point, CONMED has a negative expected return of -0.18%. Please make sure to confirm CONMED's maximum drawdown, daily balance of power, relative strength index, as well as the relationship between the skewness and day typical price , to decide if CONMED performance from the past will be repeated in the future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CONMED has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's primary indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (1.07) | Five Day Return 2.46 | Year To Date Return (4.27) | Ten Year Return 5.04 | All Time Return 11.3 K |
Forward Dividend Yield 0.0204 | Payout Ratio | Last Split Factor 3:2 | Forward Dividend Rate 0.8 | Dividend Date 2025-10-03 |
1 | Why Is Conmed Up 0.1 percent Since Last Earnings Report | 12/05/2025 |
2 | Acquisition by David Bronson of 479 shares of CONMED subject to Rule 16b-3 | 01/02/2026 |
3 | SG Americas Securities LLC Acquires 61,860 Shares of CONMED Corporation CNMD - MarketBeat | 01/13/2026 |
4 | CONMED Beats Q4 CY2025 Sales Expectations, Stock Soars | 01/28/2026 |
5 | CNMD Q4 Deep Dive Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook | 01/29/2026 |
6 | One Off US88 Million Loss And Margin Compression Test CONMED Bullish Narratives | 01/30/2026 |
7 | What To Expect From STERISs Q4 Earnings | 02/03/2026 |
| Begin Period Cash Flow | 24.3 M | |
| Total Cashflows From Investing Activities | -13.1 M |
CONMED Relative Risk vs. Return Landscape
If you would invest 4,421 in CONMED on November 6, 2025 and sell it today you would lose (542.00) from holding CONMED or give up 12.26% of portfolio value over 90 days. CONMED is currently does not generate positive expected returns and assumes 2.5575% risk (volatility on return distribution) over the 90 days horizon. In different words, 22% of stocks are less volatile than CONMED, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CONMED Target Price Odds to finish over Current Price
The tendency of CONMED Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 38.79 | 90 days | 38.79 | more than 93.0 |
Based on a normal probability distribution, the odds of CONMED to move above the current price in 90 days from now is more than 93.0 (This CONMED probability density function shows the probability of CONMED Stock to fall within a particular range of prices over 90 days) .
CONMED Price Density |
| Price |
Predictive Modules for CONMED
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CONMED. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CONMED Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CONMED is not an exception. The market had few large corrections towards the CONMED's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CONMED, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CONMED within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.29 | |
β | Beta against Dow Jones | 0.82 | |
σ | Overall volatility | 2.06 | |
Ir | Information ratio | -0.12 |
CONMED Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CONMED for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CONMED can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CONMED generated a negative expected return over the last 90 days | |
| CONMED is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from stockstory.org: What To Expect From STERISs Q4 Earnings |
CONMED Fundamentals Growth
CONMED Stock prices reflect investors' perceptions of the future prospects and financial health of CONMED, and CONMED fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CONMED Stock performance.
| Return On Equity | 0.0478 | ||||
| Return On Asset | 0.0415 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 2 B | ||||
| Shares Outstanding | 30.97 M | ||||
| Price To Earning | 188.03 X | ||||
| Price To Book | 1.18 X | ||||
| Price To Sales | 0.87 X | ||||
| Revenue | 1.37 B | ||||
| Gross Profit | 785.17 M | ||||
| EBITDA | 176.84 M | ||||
| Net Income | 132.42 M | ||||
| Cash And Equivalents | 33.35 M | ||||
| Cash Per Share | 1.09 X | ||||
| Total Debt | 905.78 M | ||||
| Debt To Equity | 1.45 % | ||||
| Current Ratio | 2.75 X | ||||
| Book Value Per Share | 32.57 X | ||||
| Cash Flow From Operations | 166.97 M | ||||
| Earnings Per Share | 1.51 X | ||||
| Market Capitalization | 1.2 B | ||||
| Total Asset | 2.31 B | ||||
| Retained Earnings | 560.28 M | ||||
| Working Capital | 361.88 M | ||||
| Current Asset | 393.34 M | ||||
| Current Liabilities | 119.72 M | ||||
About CONMED Performance
By analyzing CONMED's fundamental ratios, stakeholders can gain valuable insights into CONMED's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CONMED has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CONMED has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 198.43 | 137.98 | |
| Return On Tangible Assets | 0.17 | 0.18 | |
| Return On Capital Employed | 0.11 | 0.10 | |
| Return On Assets | 0.07 | 0.04 | |
| Return On Equity | 0.16 | 0.17 |
Things to note about CONMED performance evaluation
Checking the ongoing alerts about CONMED for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CONMED help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CONMED generated a negative expected return over the last 90 days | |
| CONMED is unlikely to experience financial distress in the next 2 years | |
| Over 99.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from stockstory.org: What To Expect From STERISs Q4 Earnings |
- Analyzing CONMED's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CONMED's stock is overvalued or undervalued compared to its peers.
- Examining CONMED's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CONMED's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CONMED's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CONMED's stock. These opinions can provide insight into CONMED's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CONMED Stock analysis
When running CONMED's price analysis, check to measure CONMED's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CONMED is operating at the current time. Most of CONMED's value examination focuses on studying past and present price action to predict the probability of CONMED's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CONMED's price. Additionally, you may evaluate how the addition of CONMED to your portfolios can decrease your overall portfolio volatility.
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |